Study Stopped
No participants recruited, study discontinued.
Molecular Epidemiology of Lymphoma Patients
1 other identifier
observational
N/A
0 countries
N/A
Brief Summary
Primary Objectives:
- 1.To enroll and obtain, through questionnaires, risk factor information on all study participants to develop detailed demographic, epidemiologic and behavioral profiles.
- 2.To assess the influence of relevant epidemiologic covariates such as age, gender, smoking and family history of cancer on the panel of susceptibility biomarkers.
- 3.To evaluate the role of genomic instability in development of lymphomas.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
Started Aug 2006
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
August 1, 2006
CompletedFirst Submitted
Initial submission to the registry
June 19, 2007
CompletedFirst Posted
Study publicly available on registry
June 20, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
April 1, 2008
CompletedFebruary 24, 2012
February 1, 2012
1.7 years
June 19, 2007
February 23, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
To identify biologic (such as genes) and lifestyle factors that may increase a person's risk of developing lymphoma.
4 Years
Study Arms (2)
Cases
Participants of study with newly diagnosed lymphoma.
Control
Participants of study from matched control group.
Interventions
Questions about cancer risk factors, medical history, and family history of cancer.
Eligibility Criteria
Participants in this study will include 400 with newly diagnosed lymphoma and 400 matched controls.
You may qualify if:
- Cases only: Newly diagnosed, previously untreated patients with lymphoma as the primary cancer.
- Age 18 years and older.
- Willing to donate 30ml of blood.
- Willing to complete a self-administered questionnaire.
- Controls only: No prior cancer.
You may not qualify if:
- Cases only: Prior history of cancer other than lymphoma.
- Unable to speak or read English
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Related Links
Biospecimen
Subjects will also provide 30 cc of blood. The blood will be genotyped, and the genotype and epidemiological data will be used to evaluate the role of genomic instability (baseline and induced) in the development of lymphomas.
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Randa El-Zein, MD, PhD
M.D. Anderson Cancer Center
Study Design
- Study Type
- observational
- Observational Model
- CASE CONTROL
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 19, 2007
First Posted
June 20, 2007
Study Start
August 1, 2006
Primary Completion
April 1, 2008
Study Completion
April 1, 2008
Last Updated
February 24, 2012
Record last verified: 2012-02